| Literature DB >> 27049630 |
Sanhita Sinharay1, Mark D Pagel1,2.
Abstract
Recent advances in magnetic resonance imaging (MRI) contrast agents have provided new capabilities for biomarker detection through molecular imaging. MRI contrast agents based on the T2 exchange mechanism have more recently expanded the armamentarium of agents for molecular imaging. Compared with T1 and T2* agents, T2 exchange agents have a slower chemical exchange rate, which improves the ability to design these MRI contrast agents with greater specificity for detecting the intended biomarker. MRI contrast agents that are detected through chemical exchange saturation transfer (CEST) have even slower chemical exchange rates. Another emerging class of MRI contrast agents uses hyperpolarized (13)C to detect the agent with outstanding sensitivity. These hyperpolarized (13)C agents can be used to track metabolism and monitor characteristics of the tissue microenvironment. Together, these various MRI contrast agents provide excellent opportunities to develop molecular imaging for biomarker detection.Entities:
Keywords: MRI contrast agents; T1; T2 exchange; T2*; chemical exchange saturation transfer; hyperpolarized 13C
Mesh：
Substances：
Year: 2016 PMID： 27049630 PMCID： PMC4911245 DOI： 10.1146/annurev-anchem-071015-041514
Source DB: PubMed Journal: Annu Rev Anal Chem (Palo Alto Calif) ISSN： 1936-1327 Impact factor: 10.745